Similarly, we found that KIF20A is highly expressed in prostate cancer by immunohistochemistry and Western blotting, and bioinformatics analysis found that high expression of KIF20A is associated with biochemical recurrence in PCa patients. The gene discussed is KIF20A; the disease is prostate carcinoma.